Patent details

Basic Information

Publication number:

EP4153194

PCT Application Number:

EP2021063164

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP217263938

PCT Publication Number:

WO2021233924

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES

French Title of Invention:

MÉTHODES D'AMÉLIORATION D'IMMUNOTHÉRAPIES PAR TRANSFERT ADOPTIF DE CELLULES

German Title of Invention:

VERFAHREN ZUR VERBESSERUNG VON ADOPTIVEN ZELLTRANSFERIMMUNTHERAPIEN

SPC Number:

Dates

Filing date:

18/05/2021

Grant date:

18/02/2026

EP Publication Date:

29/03/2023

PCT Publication Date:

25/11/2021

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/02/2026

EP B1 Publication Date:

18/02/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/05/2041

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/02/2026

 

 

Name:

Hansa Biopharma AB

Address:

Box 785, 220 07 Lund, Sweden (SE)

Inventor

Name:

KJELLMAN, Christian

Address:

Sweden (SE)

Priority

Priority Number:

202007434

Priority Date:

19/05/2020

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 35/17; A61K 38/47; A61K 38/48; A61P 31/00; A61P 35/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

202608

Publication date:

18/02/2026

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

6

Annual Fee Amount:

66 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages